NCT06687070 2025-02-26APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced STAscentage Pharma Group Inc.Phase 1 Recruiting50 enrolled
NCT02644278 2019-09-09First-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With ChemotherapyEMD SeronoPhase 1 Completed15 enrolled 13 charts